MedAccess News & Insight hub

MedAccess has reaffirmed its commitment increase access to COVID-19 vaccines via a $100m guarantee for COVAX

Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines

Results from a study in Tanzania show the Interceptor® G2 mosquito net to be highly effective at reducing malaria cases

MedAccess has welcomed Hologic’s decision to make its Aptima® SARS-CoV-2 Assay available to low- and middle-income countries under the terms of the Global Access Initiative.

MedAccess is pleased to announce the appointment of Violet Mordichai to the position of apprentice to the Board.

MedAccess has welcomed the decision by Gavi, the Vaccine Alliance to fund the world’s first mass malaria immunisation programmes using the ground-breaking RTS,S/AS01e vaccine.

MedAccess, CHAI and SD Biosensor announce partnership to make dual rapid test for syphilis and HIV available for under US$1 in over 100 low- and middle-income countries

Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess' Senior Management Team.

MedAccess' volume guarantee will help increase availability of an innovative treatment for latent tuberculosis.

Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.

MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.

Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world

Ghana will begin its COVID-19 immunisation campaign using syringes provided through MedAccess' support for UNICEF.

New support for UNICEF to secure vital COVID-19 medical products, including diagnostic tests and clinical management supplies, for low- and middle-income countries.

MedAccess is pleased to announce the appointment of Hema Srinivasan as the social finance company’s new Chief Access Officer. Hema will take up her new role in March 2020.

The price of new BASF Interceptor® G2 mosquito nets will be reduced by 40% for underserved communities thanks to a new MedAccess partnership

MedAccess has been invited to showcase how a social finance company can accelerate the delivery of new and better products in the fight against diseases.

The importance of making routine HIV tests more accessible as part of the effort to reach the U.N.’s ambitious goal to eliminate HIV transmission by the year 2030.

The Hologic Global Access Initiative was launched at the International AIDS Society Conference in July 2018, setting a new standard for affordable and transparent pricing.

Despite the efficacy and availability of quality-assured implants, evidence from national family planning programs has suggested a significant unmet need.